Principal Financial Group Inc. Has $59.23 Million Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Principal Financial Group Inc. reduced its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 2.5% in the 3rd quarter, Holdings Channel reports. The firm owned 3,252,337 shares of the company’s stock after selling 84,342 shares during the period. Principal Financial Group Inc.’s holdings in Privia Health Group were worth $59,225,000 as of its most recent filing with the SEC.

A number of other large investors have also recently added to or reduced their stakes in the stock. Sequoia Financial Advisors LLC grew its position in shares of Privia Health Group by 2.3% in the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after purchasing an additional 583 shares during the last quarter. Benjamin F. Edwards & Company Inc. grew its holdings in Privia Health Group by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock valued at $134,000 after buying an additional 605 shares during the last quarter. Arizona State Retirement System increased its position in Privia Health Group by 2.4% in the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock worth $462,000 after buying an additional 617 shares during the period. Signaturefd LLC lifted its holdings in shares of Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after buying an additional 626 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its position in shares of Privia Health Group by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock valued at $151,000 after acquiring an additional 771 shares during the period. Institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Robert W. Baird boosted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. JPMorgan Chase & Co. upped their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Barclays increased their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Truist Financial upped their price target on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, Macquarie assumed coverage on Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $24.80.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA opened at $20.07 on Monday. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $24.30. The business has a fifty day moving average of $20.30 and a two-hundred day moving average of $19.14. The stock has a market cap of $2.41 billion, a PE ratio of 200.72, a PEG ratio of 5.45 and a beta of 0.83.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.